- Home
- TLSA vs PNI Comparison
TLSA vs PNI Comparison
Compare TLSA & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- PNI
- Stock Information
- Founded
- TLSA 2013
- PNI 2002
- Country
- TLSA United Kingdom
- PNI United States
- Employees
- TLSA N/A
- PNI N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- PNI Trusts Except Educational Religious and Charitable
- Sector
- TLSA Health Care
- PNI Finance
- Exchange
- TLSA Nasdaq
- PNI Nasdaq
- Market Cap
- TLSA 187.0M
- PNI 75.2M
- IPO Year
- TLSA 2000
- PNI N/A
- Fundamental
- Price
- TLSA $1.48
- PNI $6.59
- Analyst Decision
- TLSA
- PNI
- Analyst Count
- TLSA 0
- PNI 0
- Target Price
- TLSA N/A
- PNI N/A
- AVG Volume (30 Days)
- TLSA 186.3K
- PNI 26.4K
- Earning Date
- TLSA 07-29-2025
- PNI 01-01-0001
- Dividend Yield
- TLSA N/A
- PNI 4.76%
- EPS Growth
- TLSA N/A
- PNI N/A
- EPS
- TLSA N/A
- PNI N/A
- Revenue
- TLSA N/A
- PNI N/A
- Revenue This Year
- TLSA N/A
- PNI N/A
- Revenue Next Year
- TLSA N/A
- PNI N/A
- P/E Ratio
- TLSA N/A
- PNI N/A
- Revenue Growth
- TLSA N/A
- PNI N/A
- 52 Week Low
- TLSA $0.63
- PNI $6.03
- 52 Week High
- TLSA $1.91
- PNI $7.89
- Technical
- Relative Strength Index (RSI)
- TLSA 50.51
- PNI 35.55
- Support Level
- TLSA $1.43
- PNI $6.68
- Resistance Level
- TLSA $1.54
- PNI $6.78
- Average True Range (ATR)
- TLSA 0.07
- PNI 0.07
- MACD
- TLSA -0.01
- PNI -0.01
- Stochastic Oscillator
- TLSA 47.22
- PNI 9.52
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.